UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Identification and treatment of APS renal involvement

Lupus, 2014-10, Vol.23 (12), p.1276-1278

Tektonidou, MG

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Arthritis research & therapy, 2020-03, Vol.22 (1), p.56-8, Article 56

2020

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Lupus, 2018-03, Vol.27 (3), p.399-406

2018

Link zum Volltext

Verfügbarkeit prüfen

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

Lupus, 2011-02, Vol.20 (2), p.174-181

2011

Link zum Volltext

Verfügbarkeit prüfen

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1159-1161

2004

Link zum Volltext

Verfügbarkeit prüfen

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

Lupus, 2011-02, Vol.20 (2), p.165-173

2011

Link zum Volltext

Verfügbarkeit prüfen

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study

Rheumatology (Oxford, England), 2003-05, Vol.42 (5), p.645-651

2003

Link zum Volltext

Verfügbarkeit prüfen

MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab

Lupus, 2010-09, Vol.19 (10), p.1243-1245

Tektonidou, MG

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

QJM : An International Journal of Medicine, 2000-08, Vol.93 (8), p.523-530

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparison of evidence of treatment effects in randomized and nonrandomized studies

JAMA : the journal of the American Medical Association, 2001-08, Vol.286 (7), p.821

2001

Link zum Volltext

Verfügbarkeit prüfen

Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome

Annals of the rheumatic diseases, 2001-01, Vol.60 (1), p.43-48

2001

Link zum Volltext

Verfügbarkeit prüfen

Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.159

2023

Link zum Volltext

Verfügbarkeit prüfen

EULAR recommendations for the management of antiphospholipid syndrome in adults

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1296

2019

Link zum Volltext

Verfügbarkeit prüfen

A case with epilepsy, cognitive impairment, renal microangiopathy and high titres of anticentromere and anticardiolipin antibodies

Lupus, 2005-01, Vol.14 (8), p.625-628

2005

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation

Clinical and experimental rheumatology, 2021-07, Vol.39 Suppl 131 (4), p.29

2021

Link zum Volltext

Verfügbarkeit prüfen

Guideline: EULAR provided recommendations for thrombotic and obstetric antiphospholipid syndrome

Annals of internal medicine, 2019-09, Vol.171 (6), p.JC26

DeLoughery, Thomas

2019

Link zum Volltext

Verfügbarkeit prüfen

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Autoimmunity reviews, 2014-06, Vol.13 (6), p.685-696

2014

Link zum Volltext

Verfügbarkeit prüfen

Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis

Clinical and experimental rheumatology, 2006-03, Vol.24 (2 Suppl 41), p.S103

2006

Link zum Volltext

Verfügbarkeit prüfen

The successful use of i.v. gammaglobulin for Guillain-Barré syndrome following gold therapy in an RA patient

Clinical and experimental rheumatology, 2003-05, Vol.21 (3), p.404

2003

Link zum Volltext

Verfügbarkeit prüfen

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Annals of the rheumatic diseases, 2024-01, Vol.83 (1), p.15

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.304

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis

Rheumatology (Oxford, England), 2013-03, Vol.52 (3), p.448-451

2013

Link zum Volltext

Verfügbarkeit prüfen

Paravertebral leiomyosarcoma mimicking a chronic ongoing inflammatory process

Clinical and experimental rheumatology, 2003-03, Vol.21 (2), p.237

2003

Link zum Volltext

Verfügbarkeit prüfen

Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe

Emerging infectious diseases, 2009-06, Vol.15 (6), p.956-959

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Humans
(75)
Rheumatology
(66)
Female
(48)
Adult
(38)
Male
(34)
Antiphospholipid Syndrome
(29)
Antiphospholipid Syndrome - Complications
(25)
Lupus
(20)
Middle Aged
(19)
Antiphospholipid Antibodies
(18)
Autoimmune Diseases
(18)
Systemic Lupus Erythematosus
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Pregnancy
(15)
Antiphospholipid Syndrome - Immunology
(14)
Lupus Erythematosus, Systemic - Complications
(13)
Patients
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identification and treatment of APS renal involvement

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study

MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

Comparison of evidence of treatment effects in randomized and nonrandomized studies

Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome

Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?

EULAR recommendations for the management of antiphospholipid syndrome in adults

A case with epilepsy, cognitive impairment, renal microangiopathy and high titres of anticentromere and anticardiolipin antibodies

Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation

Guideline: EULAR provided recommendations for thrombotic and obstetric antiphospholipid syndrome

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)

The successful use of i.v. gammaglobulin for Guillain-Barré syndrome following gold therapy in an RA patient

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis

Paravertebral leiomyosarcoma mimicking a chronic ongoing inflammatory process

Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe

Suchergebnisse filtern